N-Gene Research Laboratories Competitors and Similar CompaniesClear all
N-Gene Research Laboratories's competitors and similar companies include Pharmstandard, Turning Point Therapeutics, Helsinn Group and Debiopharm.
 N-Gene Research Laboratories N-Gene Research Laboratories is a company that develops drugs to treat the insulin-resistance syndrome, improve cancer chemotherapy, and slow skin aging. |  Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products. |  Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. |  Helsinn Group Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer. |  Debiopharm Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections. | |
Founding Date | Founding Date 1997 | Founding Date 2003 | Founding Date 2013 | Founding Date 1976 | Founding Date 1979 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Petrovo Dalnee, RU Tomsk, RU Ufa, RU Vol'ginskii, RU | Locations San Diego, US HQ | Locations Pazzallo, CH HQ Shanghai, CN Monaco, MC Biasca, CH Woodbridge Township, US | Locations Lausanne, CH HQ Oss, NL |
Employees | Employees 3 | Employees 1,77814% increase | Employees 474% decrease | Employees 3731% decrease | Employees 4771% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₽152.1b (FY, 2024) | Revenue (est.) $30.8m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ₽22.7b (FY, 2024) | Net income ($236.6m) (FY, 2021) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 144.4m | Total funding raised N/A | Total funding raised $ 2.1m |
For sources of this data, please see the company profile
View Company Profiles
Pharmstandard
HQ
Dolgoprudny, RU
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
View companyTurning Point Therapeutics
HQ
San Diego, US
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View companyHelsinn Group
HQ
Pazzallo, CH
Employees
373↓ 1% decrease
Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer.
View companyDebiopharm
HQ
Lausanne, CH
Employees
477↓ 1% decrease
Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections.
View company